Glossary
NCD 20.29
The Medicare National Coverage Determination that governs HBOT coverage.
NCD 20.29 is Medicare's National Coverage Determination for hyperbaric oxygen therapy. It lists the specific conditions Medicare covers and the clinical criteria that must be documented — the reference point for HBOT reimbursement.
More terms
Angiogenesis
The growth of new blood vessels — a key long-term effect of HBOT.
TcPO₂
Transcutaneous oxygen measurement used to assess wound healing potential.
Barotrauma
Injury from pressure changes, most commonly to the ears.
Stem cell mobilization
HBOT's ability to release stem cells from bone marrow into circulation.